Test catalog
NeoPainel for Cardiomyopathies and Arrhythmias
This panel analyzes a comprehensive set of genes associated with cardiomyopathies (such as hypertrophic, dilated, restrictive and arrhythmogenic) and heart rhythm disorders (arrhythmias).
- Accepted samples
- Peripheral blood (preferred), Buccal swab, Extracted DNA
- Turnaround time and when it starts
- Standard · 30 calendar days, after acceptance of the sample Fast · 15 calendar days, after acceptance of the sample
- Medical order
- Required. View requirements and limitations.
Test information
Technical details for NeoPainel for Cardiomyopathies and Arrhythmias
Method, scope, requirements and limitations
This panel analyzes a comprehensive set of genes associated with cardiomyopathies (such as hypertrophic, dilated, restrictive and arrhythmogenic) and heart rhythm disorders (arrhythmias).
- Applications
- Rare and hereditary diseases
- Accepted samples
- Peripheral blood (preferred), Buccal swab, Extracted DNA
- Estimated turnaround time
- Standard · 30 calendar days, after acceptance of the sample Fast · 15 calendar days, after acceptance of the sample
- Sequencing method
- Next-generation exome sequencing (NGS), with analysis targeted to the panel’s genes.
- Analytical scope
- Analysis of the listed genes, associated with cardiomyopathies and heart rhythm disorders, using exome data and the laboratory’s validated technical criteria.
- Genes analyzed
-
128 genes analyzed.
See full content
ABCC9, ACTC1, ACTN2, AKAP9, ALG10, ALG10B, ANK2, ANKRD1, ASCL1, BAG3, BAG5, BDNF, CACNA1C, CACNA2D1, CACNB2, CALM1, CALM2, CALM3, CASQ2, CAV3, CAVIN4, CDH2, CRYAB, CSRP3, CTNNA3, DES, DLG1, DMD, DOLK, DPP6, DSC2, DSG2, DSP, EDN3, EMD, EYA4, FHOD3, FKRP, FKTN, FLII, FLNC, GATA6, GATAD1, GDNF, GLRA1, GNB5, GPD1L, HCN4, JPH2, JUP, KCND2, KCND3, KCNE1, KCNE2, KCNE3, KCNE5, KCNH2, KCNJ2, KCNJ5, KCNJ8, KCNQ1, LAMP2, LDB3, LMNA, LMOD2, LRP5, MAOA, MLIP, MYBPC3, MYH6, MYH7, MYL2, MYLK3, MYPN, MYZAP, NEXN, NKX2-5, NOS1AP, NRAP, PHOX2B, PKP2, PLEKHM2, PLN, PPA2, PPP1R13L, PRDM16, RANGRF, RBM20, RET, RHBDF1, RPL3L, RRAGC, RYR2, SCN10A, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SGCD, SLC22A5, SLC25A4, SLC4A3, SLC6A4, SLC6A6, SLMAP, SNTA1, SPEG, TAB2, TANGO2, TAX1BP3, TBX20, TBX5, TCAP, TECRL, TGFB3, TMEM43, TNNC1, TNNI3, TNNI3K, TNNT2, TPM1, TRDN, TRPM4, TSPYL1, TTN, TTR, VCL
- Medical order
- Required
Requirements
A medical order and sufficient clinical information to guide the analysis.
Limitations
The result depends on sample quality, achieved coverage and the method’s limitations. Variants outside the validated scope may not be detected.
Additional information
The gene list, scope and turnaround times reflect the current revision. Interpretation should take clinical information and, when indicated, genetic counseling into account.
